Additive effects of beta chain mutations in low oxygen affinity hemoglobin betaF41Y,K66T

Area of Science:

• Biochemistry
• Molecular Biology
• Biophysics

Background:

• Human hemoglobin (Hb) oxygen affinity is crucial for oxygen transport.
• Modulating Hb's oxygen affinity is a key strategy for developing Hb-based blood substitutes.
• Previous studies identified mutations that decrease Hb oxygen affinity.

Purpose of the Study:

• To significantly decrease the oxygen affinity of human hemoglobin.
• To investigate the combined effects of two specific mutations (betaF41Y and K66T) on Hb function.
• To assess the potential of the double mutant for Hb-based blood substitute applications.

Main Methods:

• Site-directed mutagenesis to create a double mutant recombinant human hemoglobin (rHb betaF41Y,K66T).
• Measurement of oxygen binding affinity (P(50)) in the presence and absence of 2,3-diphosphoglycerate.
• Analysis of carbon monoxide (CO) binding kinetics to probe allosteric effects.
• Dimer-tetramer equilibrium studies to assess protein stability.

Main Results:

• The double mutation rHb betaF41Y,K66T exhibited an additive decrease in oxygen affinity compared to single mutations in the absence of 2,3-diphosphoglycerate.
• In the presence of 2,3-diphosphoglycerate, the P(50) value increase was not significantly amplified by the second mutation.
• CO binding kinetics indicated combined allosteric effects, and dimer-tetramer studies showed increased mutant stability.
• Autoxidation rates for both single and double mutants showed only a moderate increase.

Conclusions:

• The combined mutations betaF41Y and K66T effectively decrease human hemoglobin's oxygen affinity.
• The double mutant demonstrates altered allosteric properties and enhanced stability.
• These findings support the development of rHb betaF41Y,K66T as a potential component for Hb-based blood substitutes.